• LAST PRICE
    10.0300
  • TODAY'S CHANGE (%)
    Trending Down-0.1900 (-1.8591%)
  • Bid / Lots
    9.8400/ 14
  • Ask / Lots
    10.0300/ 10
  • Open / Previous Close
    10.2200 / 10.2200
  • Day Range
    Low 9.9800
    High 10.4300
  • 52 Week Range
    Low 7.6100
    High 23.1900
  • Volume
    856,694
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 10.22
TimeVolumeVIR
02:24 ET70010.045
02:26 ET661310
02:27 ET175110.05
02:29 ET254210.04
02:31 ET73010.03
02:33 ET67610.01
02:36 ET197410.02
02:38 ET41210.015
02:40 ET20010.01
02:42 ET258210.02
02:44 ET143299.99
02:45 ET311210.04
02:47 ET89810.04
02:49 ET419710.11
02:51 ET57310.115
02:54 ET110510.08
02:56 ET216110.09
02:58 ET43910.1
03:00 ET63010.09
03:02 ET197510.095
03:03 ET264310.14
03:05 ET132210.15
03:07 ET717010.17
03:09 ET95010.14
03:12 ET471110.2
03:14 ET175010.21
03:16 ET478110.23
03:18 ET65110.225
03:20 ET112610.23
03:21 ET261510.23
03:23 ET766810.27
03:25 ET248910.24
03:27 ET177510.245
03:30 ET151010.24
03:32 ET631410.18
03:34 ET157510.19
03:36 ET181810.18
03:38 ET224310.13
03:39 ET164910.13
03:41 ET780810.12
03:43 ET251210.14
03:45 ET358810.14
03:48 ET104410.13
03:50 ET609710.13
03:52 ET728910.125
03:54 ET500410.115
03:56 ET1952210.03
03:57 ET2417710.04
03:59 ET4135410.03
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVIR
Vir Biotechnology Inc
1.4B
-2.5x
---
United StatesNRIX
Nurix Therapeutics Inc
1.4B
-7.1x
---
United StatesPRTA
Prothena Corporation PLC
1.3B
-7.3x
---
United StatesIMTX
Immatics NV
1.3B
-11.7x
---
United StatesRCUS
Arcus Biosciences Inc
1.4B
-4.6x
---
United StatesGYRE
Gyre Therapeutics Inc
1.3B
-8.1x
---
As of 2024-07-20

Company Information

Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.

Contact Information

Headquarters
1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
Phone
415-906-4324
Fax
302-636-5454

Executives

Independent Chairman of the Board
Vicki Sato
Chief Executive Officer, Director
Marianne De Backer
Executive Vice President, Chief Technology Officer
Ann Hanly
Executive Vice President, Chief Scientific Officer
Jennifer Towne
Executive Vice President and Chief Business Officer
Jeffrey Calcagno

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.4B
Revenue (TTM)
$79.6M
Shares Outstanding
136.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.49
EPS
$-4.01
Book Value
$11.80
P/E Ratio
-2.5x
Price/Sales (TTM)
17.6
Price/Cash Flow (TTM)
---
Operating Margin
-780.18%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.